Nigeria: NAFDAC Warns of Counterfeit Proguanil Tablets Circulating in Market

The National Agency for Food and Drug Administration and Control (NAFDAC) has issued a public alert to healthcare professionals and the general public regarding the circulation of counterfeit Proguanil tablets branded as Projeanil and Re-Granil, both labelled as 100 mg B.P.

According to NAFDAC, the products carry NAFDAC Registration Number 04-6433, which actually belongs to a different registered product — Feroglobin B12 Capsules manufactured by Vitabiotics Nigeria. The agency said this discovery raises serious concerns about counterfeit medicines circulating in the Nigerian market.

About Proguanil

Proguanil is an antimalarial medication commonly used in combination with atovaquone (Malarone) or chloroquine to prevent and treat malaria, particularly Plasmodium falciparum infections.

NAFDAC warned that falsified and counterfeit medicines pose significant risks because they have not undergone proper laboratory evaluation, and their quality, safety, and efficacy cannot be guaranteed.

Details of the Counterfeit Products

Product 1

Product Name: Projeanil (Proguanil Tablet B.P 100mg)
Stated Manufacturer: Apple King Industry PVT, 253 A/2 Shapujat, New Delhi, India
Agent: Lifemore, 111 All Way, Ibadan
Batch Number: BN600
Manufacturing Date: 08/2024
Expiry Date: 09/2028
Fake NAFDAC Reg. No.: 04-6433

Product 2

Product Name: Re-Granil (Proguanil Tablet B.P 100mg)
Stated Manufacturer: Jamila Export LAB. PVT LTD., 401 Indraluse Estate, Mumbai Batal, India
Agent: Desmons Laboratory, 70 Ajibade Avenue, Ibadan
Batch Number: BN600
Manufacturing Date: 08/2022
Expiry Date: 09/2027
Fake NAFDAC Reg. No.: 04-6433

NAFDAC Directs Nationwide Surveillance

NAFDAC said all zonal directors and state coordinators have been instructed to conduct surveillance and remove the counterfeit products from circulation.

The agency advised distributors, retailers, healthcare professionals, and caregivers to exercise caution and avoid distributing, selling, or using the affected products. NAFDAC also emphasized that medicines should only be obtained from authorized and licensed suppliers.

Reporting and Contact Information

Healthcare professionals are advised to:

Review stocks in hospitals, clinics, and pharmacies
Report suspected counterfeit products to the nearest NAFDAC office
Call 0800-162-3322
Email sf******@********ov.ng

Adverse events or side effects can also be reported through:

NAFDAC website
Med-Safety mobile application
Email: ph***************@********ov.ng

For complaints, the public can contact NAFDAC’s Reforms Unit at:

09097630506
09097630507
re*****@********ov.ng

NAFDAC also noted that the alert will be uploaded to the World Health Organization (WHO) Global Surveillance and Monitoring System (GSMS) as part of international monitoring efforts.

The agency reiterated its commitment to safeguarding public health and preventing the circulation of counterfeit and unsafe medical products in Nigeria.

Author

Florence Akpotaire

Florence is a Media Content Specialist focused on reporting legal news, lawsuits, copyright infringement cases, and intellectual property developments. She is passionate about researching legal issues and presenting them in a clear, accessible way for readers.

Her work covers copyright disputes, trademark conflicts, court rulings, and regulatory actions across industries such as media, entertainment, technology, and business.

As part of the editorial team, Florence contributes well-researched and reliable content that helps readers stay informed about legal disputes and intellectual property matters.